VYGR 8-K 2026-10-21

Voyager Therapeutics, Inc. (VYGR) 8-K dated 2026-10-21 — accession 0001193125-26-427224. This URL is the filing, not the VYGR hub.

Voyager Therapeutics, Inc. (VYGR) is a biotechnology company listed on NASDAQ.

Voyager Therapeutics, Inc. filed a 8-K on 2026-10-21. Accession 0001193125-26-427224.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VYGR revenue for 2025-12-31 was $40.4M. Net income was -$119.7M. Revenue was down 49.5% from 2024-12-31 to 2025-12-31. VYGR currently screens at market cap $225.4M.

Not investment advice. The VYGR SEC hub lists recent forms. The stock page is the research view.